Yet we find that T cell depletion does not compensate for the Per1–/–Per2–/–-driven inhibition of tumor growth, nor do we detect immune cell transcriptional signatures in early stages of metastases formation, suggesting that the adaptive immune microenvironment does not mediate this effect. The gene discussed is PER1; the disease is neoplasm.